Alerte De Sécurité sur GEM Premier 4000 PAK Cartridges for Use on the GEM Premier 4000 System

Selon Department of Health, ce/cet/cette alerte de sécurité concerne un dispositif en/au/aux/à Hong Kong qui a été fabriqué par Instrumentation Laboratory Company.

Qu'est-ce que c'est?

Les alertes fournissent des informations importantes et des recommandations concernant les dispositifs médicaux. Le fait qu'une alerte soit émise ne signifie pas nécessairement qu'un dispositif soit dangereux. Les alertes de sécurité, qui sont envoyées tant aux travailleurs du secteur médical qu'aux utilisateurs de ces dispositifs, peuvent inclure des rappels. Elles peuvent être rédigées par des fabricants mais aussi par des autorités en charge de la santé.

En savoir plus sur les données ici
  • Type d'événement
    Safety alert
  • Date
    2011-08-03
  • Pays de l'événement
  • Source de l'événement
    DH
  • URL de la source de l'événement
  • Notes / Alertes
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notes supplémentaires dans les données
    Medical Device Safety Alert
  • Cause
    Fda class i recall: gem premier 4000 pak cartridges for use on the gem premier 4000 system it has come to our attention that the u.S. food and drug administration (fda) has issued an class i recall to remind healthcare providers and patients that gem premier 4000 pak cartridges for use on the gem premier 4000 portable critical care system, which is manufactured by instrumentation laboratory company, may give inaccurate results. potassium test results on the gem premier 4000 are too low when compared to a reference analyzer; with biases exceeding the allowable error claim of plus or minus 0.5 mmol/l by as much as 2.0 mmol/l. use of this product may lead to inappropriate patient treatment and may cause serious adverse health consequences, including death. to avoid this, the manufacturer recommended customers to follow the instructions to disable the potassium test to eliminate the potential of erroneous result reporting. according to the local supplier, hong kong is affected. the local supplier has contacted the affected customers for corrective actions for details, please refer to the following link: http://www.Fda.Gov/safety/medwatch/safetyinformation/ safetyalertsforhumanmedicalproducts/ucm266113.Htm if you are in possession of the affected product, please contact your supplier for necessary actions.

Device

Manufacturer